Stress-related mood and anxiety disorders affect millions of people in the United States. A new study examines the neurobiology behind these illnesses and finds that controlling a molecule that activates cannabinoid receptors can reduce the symptoms of anxiety.
A new study – published in the journal Nature Communications – investigates these mental disorders from a neurobiological perspective. Specifically, by using a mouse model, researchers from the Vanderbilt University Medical Center in Nashville, TN, examined the brain’s adaptability to stress and found a naturally occurring chemical that may play a key role in the development of PTSD and depression.
For More Details:
–social media marketing video
